Phase Ib-IIA study of combined check point inhibition after autologous hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Phase Ib-IIA study of combined check point inhibition after autologous hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.